NCT02906813View on ClinicalTrials.gov

A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

October 12, 2016

Study Completion Date

November 9, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-935 Tablets

Tablets

DRUG

TAK-935 Oral Solution

Oral solution

Trial Locations (1)

Unknown

Glendale

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02906813 - A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants | Biotech Hunter | Biotech Hunter